Company Presentation

Scandion Oncology A/S

Category:Clinical Stage Biotech Company
Date:April 25, 2023
Time:12:45 – 13:00
Speaker:Mads Aaboe Jensen, VP, Business development & Innovation

Company profile

Scandion Oncology discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options. We are world leaders in reverting cancer’s resistance against treatment, thus making the treatment work better and longer thereby potentially prolonging and improving the lives of patients who would otherwise have a high risk of dying from their cancer.

Follow us